reading time 2 minutes
New research reveals that three venomous snake species—including one of the most venomous snakes in the world—are even worse than we thought.
As if mambas—large, highly venomous arboreal snakes in sub-Saharan Africa—weren’t bad enough, researchers have discovered that the venoms of three mamba species have a nasty one-two-punch attack that explains why antivenoms sometimes don’t work. The study reveals that the venoms are more neurologically complex than previously believed, with significant implications for antivenom treatments.
“The Black Mamba, Western Green Mamba and Jamesons Mamba snakes aren’t just using one form of chemical weapon, they’re launching a coordinated attack at 2 different points in the nervous system,” Bryan Fry, a biologist at the University of Queensland and a co-author of a study published late last month in the journal Toxins, said in a university statement.
Mamba snake bites are responsible for 30,000 deaths every year, according to the statement. If you’re unlucky enough to be bitten by one of the aforementioned three mamba species, you’ll experience flaccid or limp paralysis. The good news is that limp paralysis is treatable by current antivenoms. The bad news is that, according to the study, these venoms then attack another part of the nervous system, triggering spastic paralysis.
“The venom first blocks nerve signals from reaching the muscles but after the antivenom is administered, it then overstimulates the muscles. It’s like treating one disease and suddenly revealing another,” Fry explained.
The study solves an enduring mystery regarding mamba victims; some patients initially seem to get better with antivenom but then start experiencing painful, uncontrolled spasms. Before this study, the researchers thought it was only the fourth species of mamba—the Eastern Green Mamba—capable of triggering spastic paralysis. Talk about a nasssssty sssssurprise.
But wait, there’s more bad news!
“We also found the venom function of the mambas was different depending on their geographic location, particularly within populations of the Black Mamba from Kenya and South Africa,” Lee Jones, a co-author of the study and a PhD candidate at the University of Queensland, said in the statement. “This further complicates treatment strategies across regions because the antivenoms are not developed to counteract the intricacies of the different venoms.”
Researchers should now seek to create specialized antivenoms to improve outcomes, Fry said. Investigating venom dynamics and the limits of current antivenoms has obvious implications for snakebite treatment, the researcher concluded.
“This kind of translational venom research can help doctors make better decisions in real time and ultimately save lives.”
P.S. What’s a snake’s favorite dance? The mamba!
Explore more on these topics
Share this story
Subscribe and interact with our community, get up to date with our customised Newsletters and much more.
It’s “an important reminder that evolutionary paths can be unpredictable.”
The rare, nonvenomous snake hasn’t been spotted since 2020, and officials are asking the public to keep an eye open for them.
Burmese pythons pose a significant threat to the Florida Everglades, but scientists have come up with a clever new way to lure and trap them.
A newly discovered cell helps pythons digest entire skeletons—and might be present in other bone-eating predators, too.
Tim Friede might be the world's most snakebit person—and his antibodies could hold the key to a truly universal snake antivenom.
While venomous, the bite of a red-bellied black snake isn't thought to be deadly.
©2025 GIZMODO USA LLC.
All rights reserved.
Source: Gizmodo